Delivery Order SPE2DR25D7059-SPE2DR26F7MSY
- Not listed
- The Defense Logistics Agency awarded a $1,033.08 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count). This competitively awarded, firm fixed-price contract is scheduled for completion by December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,361.13 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90 units. This competitive award, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $9,124.43 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Losartan-HCtz 100-12.5 mg tablets in quantities of 90 per unit. This is a firm fixed price, competitively awarded contract with a completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $3,652.50 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count). This competitively awarded, firm fixed-price contract is a non-set-aside delivery order with an ultimate completion date of December 10, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement from DLA's medical supply...
- The Defense Logistics Agency awarded a $13,934.26 delivery order to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (1,000 count) under a firm fixed-price contract. The award, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, carries no set-aside designation, indicating the contract was competitively awarded. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.45 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This award represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $7,106.46 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order was issued on November 24, 2025, with an ultimate completion date of November 25, 2025, and represents a non-set-aside procurement. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order valued at $5,776.24 to AmerisourceBergen Drug Corp for the supply of Losartan-HCT 100-25 mg tablets (90-count) on September 23, 2025, with completion expected by September 24, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity, with a ceiling value of $1,867.39. This firm fixed-price delivery order has an ultimate completion date of October 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded among...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,850.96 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MSYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,240.22 to AmerisourceBergen Drug Corp for the supply of Losartan-HCtz 100-12.5 mg tablets in a 90-day supply. This competitively awarded, firm fixed-price contract was executed on December 8, 2025, with an ultimate completion date of December 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor vehicle supports the Defense Health Agency and other federal healthcare systems by providing comprehensive pharmaceutical products and medical supplies globally. AmerisourceBergen Drug Corp's established role as a critical pharmaceutical distributor positions it to fulfill routine medication needs such as this antihypertensive agent across the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 12/7/25 |